ZBP1 and cancer: Utilizing a ZBP1-knockout mouse model coupled with single-cell RNA sequencing analysis, ZBP1 deficiency was found to significantly suppress OSCC initiation and progression, underscoring ZBP1’s critical role in modulating the TME to facilitate cancer progression.